08/14/2025
7:51 AM | Deep Track Capital, LP (Filed by)
Terns Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
07/03/2025
1:55 PM | Kuriakose Emil (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2025
4:38 PM | Gengos Andrew (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2025
5:08 PM | Burroughs Amy L. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
5:05 PM | Gengos Andrew (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
3:26 PM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2025
4:42 PM | FELLOWS DAVID A (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:43 PM | Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:43 PM | Terns Pharmaceuticals (Issuer)
Turner Heather D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:43 PM | KINDLER JEFFREY B (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
4:44 PM | Lu Hongbo (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TERN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Terns Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
06/12/2025
4:44 PM | Terns Pharmaceuticals (Issuer)
Tripuraneni Radhika (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2025
11:15 PM | Terns Pharmaceuticals (Filer)
| Form EFFECT | |
05/15/2025
7:47 AM | Deep Track Capital, LP (Filed by)
Terns Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
05/07/2025
10:29 AM | MORGAN STANLEY (Filed by)
Terns Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
04/29/2025
3:13 PM | Terns Pharmaceuticals (Filer)
| Form DEF 14A | |
04/29/2025
3:16 PM | Terns Pharmaceuticals (Filer)
| Form DEFA14A | |
04/02/2025
5:48 PM | Kuriakose Emil (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:36 PM | Terns Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/20/2025
3:23 PM | Terns Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/20/2025
3:10 PM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2025
5:10 PM | Gengos Andrew (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/25/2025
5:12 PM | Gengos Andrew (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
5:01 PM | Azelby Robert (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/24/2025
5:05 PM | Azelby Robert (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:25 PM | CITADEL ADVISORS LLC (Filed by)
Terns Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
3:15 PM | Schonfeld Strategic Advisors LLC (Filed by)
Terns Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
5:06 PM | Strauss David Eric (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
4:05 PM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
4:28 PM | BlackRock, Inc. (Filed by)
Terns Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/03/2025
6:25 PM | Burroughs Amy L. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:27 PM | Kuriakose Emil (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:28 PM | Jung Melita Sun (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:30 PM | FELLOWS DAVID A (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:31 PM | KINDLER JEFFREY B (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:35 PM | Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:36 PM | Terns Pharmaceuticals (Issuer)
Tripuraneni Radhika (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
6:37 PM | Lu Hongbo (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:30 PM | Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:30 PM | Terns Pharmaceuticals (Issuer)
Vignola Mark J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:30 PM | Kuriakose Emil (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
$100 Trillion “AI Metal” Found in American Ghost Town (Ad) Jeff Brown recently traveled to a ghost town in the middle of an American desert…
To investigate what could be the biggest technology story of this decade.
In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom…
And only one company here in the U.S. can mine this obscure metal. Click here to get the details on this virtual monopoly. |
12/16/2024
5:26 PM | Kuriakose Emil (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
5:04 PM | Burroughs Amy L. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
6:10 AM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2024
5:22 PM | Terns Pharmaceuticals (Issuer)
Turner Heather D (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/19/2024
5:30 PM | Terns Pharmaceuticals (Issuer)
Turner Heather D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
3:15 PM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
9:35 AM | Point72 Asset Management, L.P. (Filed by)
Terns Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/14/2024
6:00 PM | Terns Pharmaceuticals (Subject)
Vivo Capital Fund VIII, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:51 PM | Terns Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
11/12/2024
4:06 PM | Terns Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/05/2024
3:15 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Terns Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Terns Pharmaceuticals (Subject)
| Form SC 13G | |
09/17/2024
6:48 PM | Lu Hongbo (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:29 PM | ORBIMED ADVISORS LLC (Filed by)
Terns Pharmaceuticals (Subject)
| Form SC 13D/A | |
09/12/2024
5:10 PM | Terns Pharmaceuticals (Issuer)
Vignola Mark J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
5:01 AM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
5:00 PM | Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:09 PM | Terns Pharmaceuticals (Filer)
| Form 424B5 | |
09/09/2024
3:30 PM | Quigley Jill M. (Reporting)
Terns Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
3:40 PM | Terns Pharmaceuticals (Filer)
| Form 424B5 | |
09/09/2024
6:16 AM | Terns Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access